+ Site Statistics
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

Studies on the dynamics of biological characteristics of CD133+ cells from human umbilical cord blood during short-term culture



Studies on the dynamics of biological characteristics of CD133+ cells from human umbilical cord blood during short-term culture



Zhongguo Shi Yan Xue Ye Xue Za Zhi 11(6): 569-575



This study was to investigate dynamics of biological properties of CD133(+) cells from human umbilical cord blood (UCB) during short-term culture containing the combination of hematopoietic growth factors and the feasibility of in vitro expansion of CD133(+) cells. The biology activities including analysis of cell cycle, immunophenotype, telomerase activity, expression of adhesion molecules and expansion potential of CD133(+) cells were monitored during ex-vivo expansion, and compared with those of CD34(+) cells. The results showed that the contents of CD133(+) and CD34(+) cells in fresh UCB were (1.05 +/- 0.73)% and (1.40 +/- 0.56)% respectively. About 79.62% of CD34(+) cells expressed CD133, and more than 97% of CD133(+) cells were CD133(+)CD34(+), markedly higher than that in CD34(+) fraction (P < 0.01). No significant differences were observed in content of cells expressing CD38, CD13, CD14, CD61 and glycophorin-A between the two fractions. Expansion of CD133(+), CD133(+)CD34(+) and CD34(+)CD38(-) cells at 10 days and those of CFU-mix, HPP-CFC and CD34(+)CD38(-) cells at 6 days from CD133(+) cells group were significantly higher than those from the CD34(+) cell group (P < 0.05). Analysis of immunophenotype showed that CD133(+)CD34(+) cells declined gradually while CD133(-)CD34(+) and CD133(-)CD34(-) cells increased during ex-vivo expansion; basal telomerase activities of fresh UCB CD133(+) and CD34(+) cells were low but significantly exceeded that of CD34(-) fraction (P < 0.05). At first week of expansion, telomerase activity was significantly upregulated, after two weeks, telomerase activity remarkably declined, and decreased to baseline or below the limits of detection in day 20. More than 90% of CD133(+) cells expressed CD49d and CD11a, and, more than 85% of the cells expressed CD54, about 50% of cells expressed CD62L. At the early stage of expansion, expression of CD49d was upregulated, expression of CD11a remaining no change, while as expression of CD54 and CD62L was downregulated. Expression of all adhesion molecules was decreased gradually with extend of culture. But expression of these adhesion molecules on CD34(+) subsets were not affected significantly during expansion. It is concluded that CD133(+) population may be a more primitive hematopoietic stem/progenitor cells (HSPC) than CD34(+) cells, CD133(+) cells have great expansion potential for ex-vivo expansion and is a suitable target cell for ex-vivo expansion of HSPC. Downregulation of adhesion molecules and telomerase activity may be one of the reasons for delayed engraftment of expanded products.

Please choose payment method:






(PDF emailed within 1 workday: $29.90)

Accession: 050417845

Download citation: RISBibTeXText

PMID: 14706136


Related references

Long-term culture and identification of CD133⁺ hematopoietic progenitor cells from human umbilical cord blood. Nan Fang Yi Ke Da Xue Xue Bao 32(3): 349-353, 2012

Adherent cells generated during long-term culture of human umbilical cord blood CD34+ cells have characteristics of endothelial cells and beneficial effect on cord blood ex vivo expansion. Stem Cells 21(2): 228-235, 2003

Study on culture, identification and differentiation of CD133+ endothelial progenitor cells from human umbilical cord blood. Zhonghua Wai Ke Za Zhi 45(9): 619-622, 2007

In Vitro Differentiation of Human Umbilical Cord Blood CD133(+)Cells into Insulin Producing Cells in Co-Culture with Rat Pancreatic Mesenchymal Stem Cells. Cell Journal 17(2): 211-220, 2015

Cell cycle analysis of the CD133+ and CD133- cells isolated from umbilical cord blood. Clinica Chimica Acta; International Journal of Clinical Chemistry 343(1-2): 173-178, 2004

Co-culture of cord blood CD34(+) cells with human BM mesenchymal stromal cells enhances short-term engraftment of cord blood cells in NOD/SCID mice. CytoTherapy 9(4): 338-347, 2007

Expansion of megakaryocyte progenitors from cryopreserved leukocyte concentrates of human placental and umbilical cord blood in short-term liquid culture. CytoTherapy 3(2): 117-126, 2001

Short-term culture of umbilical cord blood-derived CD34 cells enhances engraftment into NOD/SCID mice through increased CXCR4 expression. Stem Cells and Development 18(8): 1221-1226, 2009

Ex vivo expansion of megakaryocyte progenitor cells for CD133(+) cells derived from human umbilical cord blood. Zhongguo Shi Yan Xue Ye Xue Za Zhi 16(3): 645-649, 2008

Xeno-free culture condition for human bone marrow and umbilical cord matrix-derived mesenchymal stem/stromal cells using human umbilical cord blood serum. International Journal of Reproductive Biomedicine 14(9): 567-576, 2016

Direct comparison by limiting dilution analysis of long-term culture-initiating cells in human bone marrow, umbilical cord blood, and blood stem cells. Blood 84(11): 3653-3659, 1994

The High Yield Expansion and Megakaryocytic Differentiation of Human Umbilical Cord Blood CD133(+) Cells. Cell Journal 13(3): 173-178, 2011

The cross-talk between ROS and p38MAPKα in the Ex Vivo expanded human umbilical cord blood CD133(+) cells. Journal of Huazhong University of Science and Technology. Medical Sciences 31(5): 591, 2011

Changes of differentiation and gene expression of CD133+ cells in human umbilical cord blood induced by SCF and bFGF. Zhongguo Shi Yan Xue Ye Xue Za Zhi 18(1): 146-150, 2010

Differentiation of human umbilical cord blood CD133+ stem cells towards myelo-monocytic lineage. Clinica Chimica Acta; International Journal of Clinical Chemistry 343(1-2): 85-92, 2004